#pharma — FinScans

News 📈 Stocks

Energy Transfer and Verizon Lead Dividend Picks as Pfizer Faces Debt Risks

September 20, 2026 (6 days ago)

Energy Transfer and Verizon offer attractive yields and growth, while Pfizer's high debt load and looming patent cliff make it a stock…

PFE ET VZ

🌍 AMERICAS Read More →

News 📈 Stocks

BioMarin and Ascendis Resolve Patent Dispute, Shares Rally 5% on Settlement

September 12, 2026 (14 days ago)

BioMarin and Ascendis settle a global patent dispute over the drug Yuviwel, with BioMarin securing a 20% US royalty stream and Ascendis…

BMRN ASND

🌍 GLOBAL Read More →

News 📈 Stocks

Latigo Prices IPO at $345.6 Million, Debuts as Non-Opioid Pain Drug Developer

August 7, 2026 (51 days ago)

Latigo's $345.6 million IPO highlights Wall Street's bet on non-opioid pain therapies, marking a significant entry for the biotech firm into public…

LTGO

🌍 US Read More →

News 🌐 Macro

Trump's Tariff Threat Could Trigger US Generic Drug Shortages, Hitting Pharma Stocks

July 23, 2026 (65 days ago)

Trump’s tariff threat on pharmaceutical imports raises fears of generic drug shortages, hitting pharma stocks and potentially strengthening the US dollar amid…

TEVA DXY

🌍 US Read More →

News 📈 Stocks

Bayer Sells Contraceptive Unit Stake to Apollo for €3 Billion

July 10, 2026 (78 days ago)

Bayer divests contraceptive division stake to Apollo in a €3 billion deal, boosting its balance sheet and refocusing its pharmaceutical strategy.

BAYN APO

🌍 EU Read More →

News 📈 Stocks

Bayer Stock Fate Depends on Two Court Rulings After $60 Billion Value Wipeout

June 12, 2026 (106 days ago)

Investors brace for Bayer court rulings after a $60 billion share price collapse.

BAYN

🌍 DE Read More →

News 📈 Stocks

Novo, Lilly Brace for Ozempic Patent Expirations, Seek Next Blockbuster

May 28, 2026 (121 days ago)

Novo Nordisk and Eli Lilly stocks come under scrutiny as impending Ozempic and Mounjaro patent expirations threaten the GLP-1 revenue stream, forcing…

NVO LLY

Trump’s FDA Commissioner Is Resigning With Agency in Turmoil

May 12, 2026 (137 days ago)

FDA Commissioner Marty Makary’s resignation throws the agency into turmoil, threatening drug approvals and pressuring biotech and healthcare stocks.

▼ FDA Commissioner Makary resigns

📅 Short 🌍 US Read More →